Neil Woodford’s Latest Buys and Sells: GlaxoSmithKline plc (ADR) (GSK), AstraZeneca plc (ADR) (AZN)

Page 1 of 2

LONDON — It’s always useful to see which shares the experts are buying, especially in times as uncertain as these.

Neil Woodford is as expert as they come. Through his Invesco Perpetual Income and High Income Funds, he looks after more than 22 billion pounds of client money. His High Income Fund has generated a superb 342% return over the last 15 years — outperforming the FTSE All-Share index by more than 200%.

GlaxoSmithKline PurchaseSo, what has Woodford been buying and selling? Well, the latest annual report for his 12.5 billion pound High Income Fund has just been published, and the document reveals which stocks he’s been pumping cash into and which stocks he’s been cutting back on or disposing of completely.

Security guards wanted
Woodford’s biggest company purchase from within the FTSE 100 during the period was global security group G4S plc (LON:GFS). The maestro’s timing wasn’t great on this one as he began buying before the company’s Olympic Games debacle.

However, he has since averaged down with a vengeance, bringing his total investment to over 200 million pounds. According to my calculations, his average buy price was 260 pence.

The shares have recovered nicely and are currently trading at around 290 pence, or 11.5 times forecast 2013 earnings. The earnings multiple is below the FTSE average, while a forward dividend yield of 3.2% is about in line with the market.

Hipster and hooked on drugs
Woodford’s second-largest buy from among the U.K.’s blue chips was Smith & Nephew plc (ADR) (NYSE:SNN) . The company, which makes hip-replacement and other medical devices, attracted a 175 million pound investment from Woodford.

My sums tell me he paid an average price of 632 pence for this stock, which is currently changing hands for more than 700 pence. The forward price-to-earnings (P/E) ratio of over 14 appears to be a fair rather than bargain rating, while the dividend yield is a subpar 2.3%.

Health care in general, but big pharma in particular, continues to be Woodford’s most heavily backed sector. He has been a net buyer of Europe’s five drugs giants.

The U.K.’s big two, GlaxoSmithKline plc (ADR) (NYSE:GSK) and AstraZeneca plc (ADR) (NYSE:AZN), saw continued inflows, along with France’s Sanofi and Swiss groups Roche and Novartis. Woodford dug deepest into the coffers for the last named, investing around 225 million.

Not ringing Woodford’s bell
Following his much-discussed disposal of all the fund’s shares in Tesco Corporation (USA) (NASDAQ:TESO) at the start of last year, Woodford’s biggest sale since has been Vodafone Group plc (LON:VOD) .

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Lists

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Top 10 Jobs for 2014 by Salary Gain (Predictions)

Top 5 Digital Trends for 2014

Top 6 Things You Can Do To Increase Your Productivity

Top 9 Trending Smartphones in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!